GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System

Cell-based therapies hold great promise for a myriad of clinical applications. However, as these therapies move from phase I to phase II and III trials, there is a need to improve scale-up of adherent cells for the production of larger good manufacturing practice (GMP) cell banks. As we advanced our...

Descripción completa

Detalles Bibliográficos
Autores principales: Tirughana, Revathiswari, Metz, Marianne Z., Li, Zhongqi, Hall, Christine, Hsu, David, Beltzer, Jim, Annala, Alexander J., Oganesyan, Diana, Gutova, Margarita, Aboody, Karen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037686/
https://www.ncbi.nlm.nih.gov/pubmed/29992178
http://dx.doi.org/10.1016/j.omtm.2018.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037686/
https://www.ncbi.nlm.nih.gov/pubmed/29992178
http://dx.doi.org/10.1016/j.omtm.2018.05.006

Ejemplares similares